Skip to main content

Day: April 3, 2024

60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis

Study to be conducted by North Carolina State University in 2024 Standard of care fails in 20 percent of cases and drug resistance is a problem Standard of care is expensiveWASHINGTON, April 03, 2024 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that the Company will sponsor a pilot study of tafenoquine, the active molecule in its U.S. Food and Drug Administration (FDA)-approved human malaria prevention medication, ARAKODA®, for the treatment of babesiosis in dogs. The study will support a broader effort now being led by 60 Degrees Pharmaceuticals to evaluate tafenoquine for various babesiosis indications. Tafenoquine has not been proven to be effective for treatment or prevention...

Continue reading

Stack Capital Holding Prove Identity Announces Strategic Partnership with BetMGM

Prove’s Pre-Fill® identity solution will accelerate customer onboarding, enhance security, and improve user experience across BetMGM’s entire platform TORONTO, April 03, 2024 (GLOBE NEWSWIRE) — Stack Capital Group Inc., (TSX:STCK and STCK.WT) is pleased to announce that Prove Identity, Inc. (“Prove”), an existing portfolio holding, has entered into a strategic partnership with BetMGM, a market-leading sports betting and gaming entertainment company which operates leading brands such as BetMGM, Borgata Casino, Party Casino, and Party Poker. Pending regulatory approval, the partnership will allow BetMGM to utilize Prove’s Pre-Fill® identity solution across its entire sports betting platform, including all of MGM’s U.S. land-based and online sports betting, major tournament poker, and online gaming businesses. Accelerated customer...

Continue reading

Red Pine Continues to Intercept Significant Mineralization at the Wawa Gold Project, including 4.53 g/t over 11.53 metres including 15.00 g/t gold over 1.14 metres

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) is pleased to announce assay results from 14 drill holes representing 5,390 metres (“m”) of diamond drilling from the 2023-2024 resource expansion program at the Wawa Gold Project. The drilling continues the program commenced in 2021 with a total of (“121”) drill holes for ~54,800 m having now been completed and released from the current targeted program of approximately 65,000 to 70,000 metres of resource expansion drilling leading to an updated resource estimate. Drilling Highlights: Contained within the Jubilee Shear System (Table 1)4.53 grams per tonne (“g/t”) gold over 11.53 m, including 15.00 g/t gold over 1.14 m in SD-24-495 4.96 g/t gold over 7.87 m, including 16.50 g/t gold over 0.97 m in SD-24-490...

Continue reading

HEALWELL AI to Participate in Upcoming Investor Conferences

LD Micro Invitational XIV on April 8-9, 2024, in New York City, NY Bloom Burton & Co. Healthcare Investor Conference on April 16-17, 2024, in Toronto, ON Planet MicroCap Showcase: VEGAS 2024 on April 30 to May 2, 2024, in Las Vegas, NVTORONTO, April 03, 2024 (GLOBE NEWSWIRE) — HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX) (OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce that Dr. Alexander Dobranowski, CEO of HEALWELL AI, will be participating in the following upcoming investor conferences: LD Micro Invitational XIVPresentation Date: April 9, 2024Presentation Time: 11:00 am ET (8:00 am PT) – Track 3 Hosted at the Sofitel New York from April 8-9, 2024, the 14th annual LD Micro Invitational introduces investors to presenting companies...

Continue reading

Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024

REYKJAVIK, Iceland, April 03, 2024 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will host an audio call with a market update at 12:15 pm GMT / 08:15 am EDT on April 3, 2024. Anil Okay, Chief Commercial Officer, will be providing the update. Information on how to access the webcast is posted on Alvotech’s investor website at https://investors.alvotech.com/events/event-details/market-update-2024-04-03. The webcast will be archived and available for replay for 90 days after the event. About AlvotechAlvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in...

Continue reading

Green Thumb Industries to Hold First Quarter 2024 Earnings Conference Call on May 8, 2024

CHICAGO and VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced it will release first quarter 2024 financial results after the market closes on Wednesday, May 8, 2024. A conference call and audio webcast will also be held on Wednesday, May 8, 2024, at 5:00 p.m. Eastern Time/4:00 p.m. Central Time to discuss the results and answer any questions.Live conference call: 844-883-3895 (Toll-Free) and 412-317-5797 (International) Live and archived webcast: https://investors.gtigrows.comParticipants may pre-register for the live conference call any time prior to the start of the call by navigating to https://dpregister.com/sreg/10187760/fc11574a50...

Continue reading

Howard Hughes Announces First Four Homebuilders for Teravalis™

Lennar, Brightland Homes, KB Home, and Courtland Communities Slated to Build Homes for Launch of New Howard Hughes Community in Phoenix West ValleyAerial of Teravalis Amenity Center with Reclaimed Water ViewAerial of Teravalis Amenity Center with Reclaimed Water View, Courtesy of Howard HughesTeravalis Community EntranceTeravalis Community Entrance, Courtesy of Howard HughesPHOENIX, April 03, 2024 (GLOBE NEWSWIRE) — Howard Hughes Holdings Inc. (NYSE: HHH) announced today the first four homebuilders for the launch of Teravalis™, the company’s new 37,000-acre community in the Phoenix West Valley. Lennar, Brightland Homes, KB Home, and Courtland Communities will build the initial homes in Floreo, the first village being developed in Teravalis, that is expected to deliver the community’s first 5,000 homes...

Continue reading

Lumine Group Enters into an Agreement to Acquire Casa Systems’ Axyom Cloud Native 5G Core Software & RAN Assets

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) — Lumine Group Inc. (“Lumine Group” or “the Company”) (TSXV: LMN), a global buy-and-hold forever acquirer of communications and media software businesses, today announced that it has entered into an asset purchase agreement to acquire the Axyom Cloud Native 5G Core Software & RAN Assets (“Assets”) from Casa Systems (Nasdaq: CASA). Casa Systems intends to facilitate the sale of its businesses, including the Assets, through a Chapter 11 process. This will mark Lumine Group’s 14th corporate carve-out that it has completed and set up in the communications and media space. The Assets provide cloud native 5G network functions (CNFs) in the core and access networks. Solutions include Access & Mobility Management, Session Management, User Plane, Network Repository, and Network Slicing...

Continue reading

BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Recent acquisition of Adaptive Phage Therapeutics creates leader in phage therapy with advanced, clinical-stage pipeline     Closed concurrent $50 million financing to support BX004 and BX211 programs through key data readouts expected in 2025  Patient recruitment on track in BX211 Phase 2 trial in Diabetic Foot Osteomyelitis (“DFO”), with topline results expected in Q1 2025 Company will host a conference call and webcast today at 8:00 am ET    CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 03, 2024 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update. “2023...

Continue reading

ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium

BAUDETTE, Minn., April 03, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will host investor meetings at the Piper Sandler Spring Biopharma Symposium on Wednesday, April 17, 2024, at the Encore Boston Harbor. To schedule a 1×1 meeting with the Company, please email corporateaccess@psc.com. About ANI ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.